Argent Biopharma (RGTLF) Revenue
Argent Biopharma Revenue
Argent Biopharma had a revenue of -90.91K in the quarter ending Jun 30, 2025, with -1663.11%. This bring the company's revenue in the last twelve months to 161.19K, Decreased 62.37%. In the fiscal year ending Jun 30, 2025, Argent Biopharma had annual revenue of 161.19K with -72.37% growth.
- Revenue (ttm)
- 161.19K
- Revenue Growth
- 15.15%
- P/S Ratio
- 12.85
- Revenue/Employee
- $32,237
- Employees
- 5
- Market Cap
- $2.07M
Revenue Chart
Argent Biopharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 161.19K | -422.26K | -72.37% |
| Jun 30, 2024 | 583.45K | -307.64K | -34.52% |
| Jun 30, 2023 | 891.08K | -2.50M | -73.70% |
| Jun 30, 2022 | 3.39M | -1.34M | -28.41% |
| Jun 30, 2021 | 4.73M | 1.74M | 57.94% |
| Jun 30, 2020 | 3.00M | 916.88K | 44.10% |
| Jun 30, 2020 | 2.08M | 1.42M | 216.83% |
| Jun 30, 2019 | 656.24K | 359.43K | 121.10% |
| Jun 30, 2018 | 296.81K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.